APPROVE Trial: Evaluating a Prescription Digital Therapeutic for Treatment of OAB in Women
Conditions
Overactive Bladder (OAB) · Urinary Urgency · Urinary Urge Incontinence (UUI) · Nocturia · Urinary Frequency
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
University of Alabama at Birmingham, Birmingham, Alabama, United States
Contact: Principal Investigator (Gabriela Halder, MD)Holly Richter, MD (Sub-investigator)Gena Dunivan, MD (Sub-investigator)David Ellington, MD (Sub-investigator)Thomas Powell, MD (Sub-investigator)Stanford University, Palo Alto, California, United States
Contact: Principal Investigator (Eric Sokol, MD)MedStar Health, Washington D.C., District of Columbia, United States
Contact: Principal Investigator (Robert Gutman, MD)Cheryl Iglesia, MD (Sub-investigator)Lee Ann Richter, MD (Sub-investigator)Andrew Sokol, MD (Sub-investigator)Alexis Dieter, MD (Sub-investigator)University of Chicago, Chicago, Illinois, United States
Contact: Principal Investigator (Margaret Mueller, MD)Curavit, Boston, Massachusetts, United States
Atrium Health Wake Forest Baptist, Winston-Salem, North Carolina, United States
Contact: Principal Investigator (Candace Parker-Autry, MD)Allegheny Health, Pittsburgh, Pennsylvania, United States
Contact: Principal Investigator (Erin Lavelle, MD)Medical University of South Carolina Health, Charleston, South Carolina, United States
Contact: Principal Investigator (Amy Askew, MD)UT Southwestern Medical Center, Dallas, Texas, United States
Contact: Principal Investigator (Maria E. Florian-Rodriguez, MD, FACOG)University of Wisconsin, Madison, Wisconsin, United States
Contact: Principal Investigator (Jon Pennycuff, MD)